To date, Moderna’s COVID-19 vaccine has only been tested on adults, but according to a recent KOAT Action News article, that’s about to change. A team of scientists at the University of New Mexico Hospital are preparing to test the Moderna vaccine on children aged 6 months to 12 years. The open-label placebo-controlled study will test safety, tolerability, and effectiveness of two doses administered 4 weeks apart. The subjects will be monitored for 12 months, after the second shot.
UNMH is Testing the Moderna Vaccine in Children
The trial will include 6,750 healthy children between 6 months and 12 years old.
Apr 9, 2021
Recommended
Recommended
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
